195 related articles for article (PubMed ID: 20974237)
1. Analysis of lipid nanoparticles by Cryo-EM for characterizing siRNA delivery vehicles.
Crawford R; Dogdas B; Keough E; Haas RM; Wepukhulu W; Krotzer S; Burke PA; Sepp-Lorenzino L; Bagchi A; Howell BJ
Int J Pharm; 2011 Jan; 403(1-2):237-44. PubMed ID: 20974237
[TBL] [Abstract][Full Text] [Related]
2. Polydispersity characterization of lipid nanoparticles for siRNA delivery using multiple detection size-exclusion chromatography.
Zhang J; Haas RM; Leone AM
Anal Chem; 2012 Jul; 84(14):6088-96. PubMed ID: 22816783
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of cationic nanoparticles of biodegradable copolymers as siRNA delivery system for hepatitis B treatment.
Wang J; Feng SS; Wang S; Chen ZY
Int J Pharm; 2010 Nov; 400(1-2):194-200. PubMed ID: 20801205
[TBL] [Abstract][Full Text] [Related]
4. Structure of self-organized multilayer nanoparticles for drug delivery.
Gerelli Y; Barbieri S; Di Bari MT; Deriu A; Cantù L; Brocca P; Sonvico F; Colombo P; May R; Motta S
Langmuir; 2008 Oct; 24(20):11378-84. PubMed ID: 18816016
[TBL] [Abstract][Full Text] [Related]
5. Self-assembled biodegradable micellar nanoparticles of amphiphilic and cationic block copolymer for siRNA delivery.
Sun TM; Du JZ; Yan LF; Mao HQ; Wang J
Biomaterials; 2008 Nov; 29(32):4348-55. PubMed ID: 18715636
[TBL] [Abstract][Full Text] [Related]
6. Preparation and characterization of poly(DL-lactide-co-glycolide) nanoparticles for siRNA delivery.
Cun D; Foged C; Yang M; Frøkjaer S; Nielsen HM
Int J Pharm; 2010 May; 390(1):70-5. PubMed ID: 19836438
[TBL] [Abstract][Full Text] [Related]
7. Enhanced siRNA delivery using cationic liposomes with new polyarginine-conjugated PEG-lipid.
Kim HK; Davaa E; Myung CS; Park JS
Int J Pharm; 2010 Jun; 392(1-2):141-7. PubMed ID: 20347025
[TBL] [Abstract][Full Text] [Related]
8. Self-assembling polyethylenimine derivatives mediate efficient siRNA delivery in mammalian cells.
Creusat G; Zuber G
Chembiochem; 2008 Nov; 9(17):2787-9. PubMed ID: 18972467
[No Abstract] [Full Text] [Related]
9. Interaction of cholesterol-conjugated ionizable amino lipids with biomembranes: lipid polymorphism, structure-activity relationship, and implications for siRNA delivery.
Zhang J; Fan H; Levorse DA; Crocker LS
Langmuir; 2011 Aug; 27(15):9473-83. PubMed ID: 21648950
[TBL] [Abstract][Full Text] [Related]
10. Morphological observations on a lipid-based drug delivery system during in vitro digestion.
Fatouros DG; Bergenstahl B; Mullertz A
Eur J Pharm Sci; 2007 Jun; 31(2):85-94. PubMed ID: 17418543
[TBL] [Abstract][Full Text] [Related]
11. Amine-functionalized gold nanoparticles as non-cytotoxic and efficient intracellular siRNA delivery carriers.
Lee SH; Bae KH; Kim SH; Lee KR; Park TG
Int J Pharm; 2008 Nov; 364(1):94-101. PubMed ID: 18723087
[TBL] [Abstract][Full Text] [Related]
12. The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing.
Liu X; Howard KA; Dong M; Andersen MØ; Rahbek UL; Johnsen MG; Hansen OC; Besenbacher F; Kjems J
Biomaterials; 2007 Feb; 28(6):1280-8. PubMed ID: 17126901
[TBL] [Abstract][Full Text] [Related]
13. Physicochemical characterization techniques for lipid based delivery systems for siRNA.
Kapoor M; Burgess DJ; Patil SD
Int J Pharm; 2012 May; 427(1):35-57. PubMed ID: 21979250
[TBL] [Abstract][Full Text] [Related]
14. Gold nanoparticles generated in ethosome bilayers, as revealed by cryo-electron-tomography.
de la Presa P; Rueda T; del Puerto Morales M; Javier Chichón F; Arranz R; Valpuesta JM; Hernando A
J Phys Chem B; 2009 Mar; 113(10):3051-7. PubMed ID: 19708264
[TBL] [Abstract][Full Text] [Related]
15. Structural investigations on nanoemulsions, solid lipid nanoparticles and nanostructured lipid carriers by cryo-field emission scanning electron microscopy and Raman spectroscopy.
Saupe A; Gordon KC; Rades T
Int J Pharm; 2006 May; 314(1):56-62. PubMed ID: 16574354
[TBL] [Abstract][Full Text] [Related]
16. Delivery of DNA and siRNA by novel gemini-like amphiphilic peptides.
Damen M; Aarbiou J; van Dongen SF; Buijs-Offerman RM; Spijkers PP; van den Heuvel M; Kvashnina K; Nolte RJ; Scholte BJ; Feiters MC
J Control Release; 2010 Jul; 145(1):33-9. PubMed ID: 20381554
[TBL] [Abstract][Full Text] [Related]
17. Stability of lipid excipients in solid lipid nanoparticles.
Radomska-Soukharev A
Adv Drug Deliv Rev; 2007 Jul; 59(6):411-8. PubMed ID: 17553589
[TBL] [Abstract][Full Text] [Related]
18. Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy.
Lombardi Borgia S; Regehly M; Sivaramakrishnan R; Mehnert W; Korting HC; Danker K; Röder B; Kramer KD; Schäfer-Korting M
J Control Release; 2005 Dec; 110(1):151-63. PubMed ID: 16297487
[TBL] [Abstract][Full Text] [Related]
19. Formation of core/shell nanoparticles with a lipid core and their application as a drug delivery system.
Oh KS; Lee KE; Han SS; Cho SH; Kim D; Yuk SH
Biomacromolecules; 2005; 6(2):1062-7. PubMed ID: 15762679
[TBL] [Abstract][Full Text] [Related]
20. Targeted SAINT-O-Somes for improved intracellular delivery of siRNA and cytotoxic drugs into endothelial cells.
Adrian JE; Morselt HW; Süss R; Barnert S; Kok JW; Asgeirsdóttir SA; Ruiters MH; Molema G; Kamps JA
J Control Release; 2010 Jun; 144(3):341-9. PubMed ID: 20226822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
